Warning! GuruFocus detected
2 Severe warning signs
with PHG.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Koninklijke Philips NV
ISIN : ARDEUT110558
Share Class Description:
BUE:PHG: CedearDescription
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, and image-guided therapy solutions. The connected care segment (around 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal care products.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.32 | |||||
| Equity-to-Asset | 0.41 | |||||
| Debt-to-Equity | 0.62 | |||||
| Debt-to-EBITDA | 16.04 | |||||
| Interest Coverage | 1.5 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 1.61 | |||||
| Beneish M-Score | -2.9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 4.9 | |||||
| 3-Year EBITDA Growth Rate | 0.6 | |||||
| 3-Year EPS without NRI Growth Rate | -3.1 | |||||
| 3-Year FCF Growth Rate | 4.2 | |||||
| 3-Year Book Growth Rate | -5.5 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 12.2 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 4.41 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 11.22 | |||||
| 9-Day RSI | 22.26 | |||||
| 14-Day RSI | 30.64 | |||||
| 3-1 Month Momentum % | 6.4 | |||||
| 6-1 Month Momentum % | -20.6 | |||||
| 12-1 Month Momentum % | 9501.18 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.23 | |||||
| Quick Ratio | 0.84 | |||||
| Cash Ratio | 0.3 | |||||
| Days Inventory | 122.3 | |||||
| Days Sales Outstanding | 73.52 | |||||
| Days Payable | 66.45 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward Dividend Yield % | 3.18 | |||||
| 3-Year Average Share Buyback Ratio | 0.5 | |||||
| Shareholder Yield % | 1.49 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 43.13 | |||||
| Operating Margin % | 2.85 | |||||
| Net Margin % | -3.9 | |||||
| FCF Margin % | 5.23 | |||||
| ROE % | -5.87 | |||||
| ROA % | -2.4 | |||||
| ROIC % | -20.01 | |||||
| 3-Year ROIIC % | 380.37 | |||||
| ROC (Joel Greenblatt) % | 17.53 | |||||
| ROCE % | 2.24 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 0.69 | |||||
| PE Ratio without NRI | 15.04 | |||||
| Shiller PE Ratio | 20.49 | |||||
| PS Ratio | 1.09 | |||||
| PB Ratio | 1.6 | |||||
| Price-to-Free-Cash-Flow | 21.7 | |||||
| Price-to-Operating-Cash-Flow | 12.36 | |||||
| EV-to-EBIT | 52.11 | |||||
| EV-to-Forward-EBIT | 13.59 | |||||
| EV-to-EBITDA | 52.11 | |||||
| EV-to-Forward-EBITDA | 8.52 | |||||
| EV-to-Revenue | 1.35 | |||||
| EV-to-Forward-Revenue | 1.27 | |||||
| EV-to-FCF | 27.25 | |||||
| Price-to-GF-Value | 1.18 | |||||
| Price-to-Projected-FCF | 1.12 | |||||
| Price-to-Median-PS-Value | 0.7 | |||||
| Earnings Yield (Greenblatt) % | 1.92 | |||||
| FCF Yield % | 4.65 | |||||
| Forward Rate of Return (Yacktman) % | -19.84 |
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers